— Know what they know.
Not Investment Advice
Also trades as: 1177.HK (HKSE) · $vol 68M · SBHMY (OTC) · $vol 0M

SBMFF OTC

Sino Biopharmaceutical Limited
1W: +0.0% 1M: -5.8% 3M: +17.2% YTD: -20.3% 1Y: -36.2% 3Y: +111.9% 5Y: -9.8%
$0.69
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 41 · $12.4B mcap · 9.12B float · 0.0000% daily turnover · Short 80% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
5
ROE
3
ROA
5
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SBMFF receives an overall rating of B+. Strongest factors: DCF (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-09-03 B B+
2026-08-21 B+ B
2026-08-14 B B+
2026-07-17 B- B
2026-07-09 C B-
2026-07-07 None ADDED
2026-07-07 EXISTED None
2026-07-01 None ADDED
2026-06-23 EXISTED None
2026-06-18 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
80
Balance Sheet
84
Earnings Quality
66
Growth
78
Value
—
Momentum
90
Safety
—
Cash Flow
59

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
7/9
✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓
Beneish M-Score
-1.64
Possible Manipulator
Ohlson O-Score
-9.80
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 74.6/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 0.95x
Accruals: 0.5%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SBMFF scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SBMFF's score of -1.64 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SBMFF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SBMFF receives an estimated rating of A (score: 74.6/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SBMFF's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
35.80x
PEG
-0.88x
P/S
2.52x
P/B
2.64x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$3.92
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 35.8x earnings, SBMFF commands a growth premium. Graham's intrinsic value formula yields $3.92 per share, suggesting a potential 464% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.513
NI / EBT
×
Interest Burden
1.328
EBT / EBIT
×
EBIT Margin
0.271
EBIT / Rev
×
Asset Turnover
0.498
Rev / Assets
×
Equity Multiplier
2.303
Assets / Equity
=
ROE
21.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SBMFF's ROE of 21.1% is driven by Asset Turnover (0.498), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.51 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$14.55
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SBMFF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. SBMFF trades at a premium to its adjusted intrinsic value of $14.55, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 35.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.69
Median 1Y
$0.16
5th Pctile
$0.01
95th Pctile
$3.00
Ann. Volatility
172.5%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
ROE 12.3% 17.3% 20.7% 38.5% 41.7% 62.1% 55.9% 29.4% 17.6% 6.9% 5.7% 4.6% 8.3% 13.7% 12.6% 11.3% 11.1% 11.7% 16.6% 21.1% 21.15%
ROA 6.4% 7.9% 9.0% 17.3% 20.4% 27.1% 23.9% 13.3% 8.5% 3.3% 2.6% 2.1% 4.0% 6.5% 5.9% 5.3% 5.2% 5.5% 7.2% 9.2% 9.18%
ROIC 15.7% 29.1% 19.2% 16.6% 16.1% 15.6% 16.8% 16.1% 17.5% 17.4% 18.0% 17.8% 16.7% 19.1% 20.7% 21.0% 22.2% 22.2% 32.7% 40.0% 40.01%
ROCE 9.3% 14.8% 17.8% 30.7% 29.3% 28.2% 23.4% 9.8% 12.1% 12.3% 13.7% 13.6% 12.6% 14.5% 12.7% 11.3% 10.3% 10.2% 13.5% 17.8% 17.83%
Gross Margin 76.6% 79.9% 80.5% 81.2% 79.4% 79.4% 80.5% 80.5% 79.1% 97.3% 78.7% 78.7% 82.1% 82.1% 80.8% 80.8% 82.5% 82.5% 83.0% 83.0% 83.05%
Operating Margin 22.8% 16.6% 17.2% 25.0% 12.9% 12.9% 20.8% 20.8% 20.0% 21.4% 20.5% 20.5% 22.7% 22.7% 18.4% 18.4% 21.4% 21.4% 35.2% 35.2% 35.17%
Net Margin 17.3% 25.0% 26.4% 92.4% 49.0% 49.0% 12.6% 12.6% 4.6% -4.3% 8.2% 8.2% 19.0% 19.0% 3.7% 3.7% 19.3% 19.3% 17.7% 17.7% 17.66%
EBITDA Margin 29.8% 16.6% 45.6% 1.2% 16.3% 16.3% 23.3% 23.3% 23.6% 27.5% 23.9% 23.9% 24.9% 24.9% 16.8% 16.7% 22.4% 22.4% 36.5% 36.5% 36.48%
FCF Margin 15.6% 15.1% 14.3% 13.8% 13.6% 13.5% 16.3% 18.9% 18.1% 19.3% 16.6% 13.9% 15.1% 14.7% 15.7% 17.9% 17.8% 17.6% 16.9% 15.4% 15.44%
OCF Margin 23.1% 22.5% 21.6% 21.0% 21.1% 21.2% 23.3% 25.2% 23.4% 24.1% 21.6% 19.1% 19.7% 18.5% 19.8% 21.6% 21.2% 20.7% 19.1% 17.5% 17.47%
ROE 3Y Avg snapshot only 12.19%
ROE 5Y Avg snapshot only 21.43%
ROA 3Y Avg snapshot only 5.23%
ROIC 3Y Avg snapshot only 22.49%
ROIC Economic snapshot only 18.09%
Cash ROA snapshot only 7.77%
Cash ROIC snapshot only 29.19%
CROIC snapshot only 25.80%
NOPAT Margin snapshot only 23.95%
Pretax Margin snapshot only 35.94%
R&D / Revenue snapshot only 16.93%
SGA / Revenue snapshot only 37.21%
SBC / Revenue snapshot only 0.07%
Valuation
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 35.804
P/S Ratio — — — — — — — — — — — — — — — — — — — — 2.517
P/B Ratio — — — — — — — — — — — — — — — — — — — — 2.639
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
Graham Number snapshot only $3.92
Leverage & Solvency
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Current Ratio 3.06 2.08 2.10 2.07 1.53 1.53 1.55 1.55 1.29 1.29 1.00 1.00 1.15 1.15 1.26 1.26 1.36 1.36 1.63 1.63 1.630
Quick Ratio 2.88 1.91 1.93 1.92 1.41 1.41 1.42 1.42 1.17 1.17 0.93 0.93 1.07 1.07 1.14 1.14 1.28 1.28 1.56 1.56 1.557
Debt/Equity 0.45 0.85 0.74 0.56 0.40 0.40 0.40 0.40 0.47 0.47 0.38 0.39 0.29 0.29 0.31 0.31 0.36 0.36 0.53 0.53 0.527
Net Debt/Equity -0.13 -0.13 0.19 0.13 -0.12 -0.12 -0.12 -0.12 -0.10 -0.10 -0.14 -0.14 -0.11 -0.11 -0.15 -0.15 -0.24 -0.24 -0.32 -0.32 -0.320
Debt/Assets 0.22 0.30 0.28 0.24 0.20 0.20 0.18 0.19 0.22 0.22 0.18 0.18 0.15 0.15 0.15 0.15 0.16 0.16 0.21 0.21 0.206
Debt/EBITDA 2.32 2.57 1.80 0.96 0.89 0.88 0.98 2.16 2.28 2.24 1.82 1.81 1.44 1.27 1.42 1.60 1.95 1.96 2.00 1.56 1.557
Net Debt/EBITDA -0.69 -0.40 0.45 0.23 -0.26 -0.27 -0.30 -0.66 -0.46 -0.47 -0.66 -0.65 -0.52 -0.46 -0.70 -0.79 -1.29 -1.29 -1.21 -0.94 -0.943
Interest Coverage 14.44 20.21 27.95 57.62 90.08 86.52 150.94 — — — — — — — — — — — — — —
Equity Multiplier 2.09 2.82 2.63 2.29 2.00 2.00 2.15 2.15 2.15 2.15 2.19 2.19 2.03 2.03 2.05 2.05 2.24 2.24 2.55 2.55 2.555
Cash Ratio snapshot only 1.020
Cash to Debt snapshot only 1.606
FCF to Debt snapshot only 0.333
Defensive Interval snapshot only 696.7 days
Efficiency & Turnover
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Asset Turnover 0.38 0.45 0.43 0.41 0.41 0.50 0.48 0.46 0.45 0.42 0.40 0.40 0.42 0.48 0.46 0.44 0.42 0.43 0.45 0.50 0.498
Inventory Turnover 3.12 2.93 2.95 2.91 2.79 2.79 2.73 2.86 2.66 2.10 2.23 2.30 2.30 2.93 2.60 2.43 2.77 2.83 2.75 2.94 2.938
Receivables Turnover 6.14 8.41 8.41 5.40 6.54 7.46 6.64 5.54 6.33 5.83 4.32 4.33 4.56 5.22 4.97 4.76 3.81 3.92 4.32 4.72 4.719
Payables Turnover 2.21 2.76 2.18 2.33 2.48 2.85 2.06 2.36 3.08 2.44 1.77 1.83 2.35 2.99 3.12 2.91 2.18 2.22 3.26 3.48 3.482
DSO 59 43 43 68 56 49 55 66 58 63 84 84 80 70 73 77 96 93 84 77 77.3 days
DIO 117 125 124 125 131 131 134 127 137 174 164 159 159 125 140 150 132 129 133 124 124.2 days
DPO 165 132 167 157 147 128 177 155 118 150 206 200 155 122 117 125 168 164 112 105 104.8 days
Cash Conversion Cycle 11 36 0 36 40 51 11 39 77 87 42 43 83 73 97 102 60 58 105 97 96.7 days
Fixed Asset Turnover snapshot only 3.676
Operating Cycle snapshot only 201.6 days
Cash Velocity snapshot only 1.342
Capital Intensity snapshot only 2.248
Growth (YoY)
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Revenue -5.9% -2.4% 1.7% 4.1% 13.4% 13.6% 10.3% 9.3% 8.1% -3.1% -4.2% -5.7% -3.5% 19.7% 15.1% 10.6% 9.0% -1.9% 12.6% 28.2% 28.24%
Net Income -58.1% 25.9% 57.5% 1.9% 2.4% 2.5% 1.6% -25.5% -59.0% -85.9% -87.3% -82.6% -51.0% 1.1% 1.2% 1.5% 42.1% -9.5% 37.5% 95.0% 94.96%
EPS -58.4% 26.0% 54.1% 2.0% 2.3% 2.4% 1.6% -24.9% -58.2% -85.6% -87.0% -82.1% -49.8% 1.1% 1.3% 1.6% 45.6% -7.5% 38.5% 96.4% 96.37%
FCF 1.3% 0.5% -0.4% -1.3% -1.1% 2.1% 25.5% 49.4% 44.3% 38.1% -2.5% -30.8% -19.9% -8.6% 9.3% 43.1% 28.8% 17.6% 21.1% 10.5% 10.47%
EBITDA 11.9% -13.0% 21.7% 1.2% 1.2% 1.5% 59.7% -60.9% -54.9% -54.5% -48.3% 14.3% 9.4% 21.5% 8.8% -3.8% -9.2% -19.6% 24.8% 80.1% 80.10%
Op. Income -0.9% -15.8% -14.2% -11.1% -8.7% -5.2% 0.7% -7.9% 12.3% 16.3% 8.0% 12.1% 8.7% 24.9% 18.5% 12.0% 4.8% -8.6% 31.7% 77.0% 76.98%
OCF Growth snapshot only 3.51%
Asset Growth snapshot only 27.21%
Equity Growth snapshot only 1.90%
Debt Growth snapshot only 75.51%
Shares Change snapshot only -0.72%
Dividend Growth snapshot only 50.04%
Growth (CAGR)
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Revenue 3Y 15.3% 16.9% 16.5% 14.1% 11.0% 8.7% 6.6% 5.4% 4.9% 2.4% 2.4% 2.3% 5.8% 9.6% 6.8% 4.4% 4.4% 4.4% 7.5% 10.1% 10.15%
Revenue 5Y 13.9% 14.2% 14.3% 14.1% 14.3% 13.6% 13.3% 13.4% 13.5% 11.9% 10.8% 8.9% 7.4% 8.3% 6.0% 4.0% 4.0% 4.8% 6.9% 8.7% 8.74%
EPS 3Y 17.1% 14.0% 27.0% 63.4% 70.3% 15.4% 13.9% -4.5% -16.6% -15.0% -19.0% -26.4% -11.2% 1.3% -7.4% -30.0% -32.7% -34.3% -25.4% -3.5% -3.52%
EPS 5Y 18.5% 20.1% 22.8% 42.2% 46.0% 49.1% 45.1% 31.5% 17.5% -6.3% -6.7% -10.1% 0.7% -14.0% -15.1% -16.8% -15.8% 3.9% 11.1% 14.9% 14.90%
Net Income 3Y 20.5% 24.1% 30.1% 64.3% 71.4% 17.3% 14.4% -4.1% -16.5% -14.5% -19.4% -27.6% -12.1% 1.0% -9.2% -31.3% -34.2% -35.8% -26.8% -5.4% -5.36%
Net Income 5Y 21.6% 22.7% 26.4% 46.4% 50.2% 53.5% 49.1% 32.8% 19.5% -1.1% -6.1% -10.5% 0.2% -13.9% -15.7% -17.4% -16.5% 3.3% 10.1% 13.2% 13.15%
EBITDA 3Y 15.8% 9.6% 19.6% 43.3% 35.4% 40.6% 33.0% 0.2% 3.9% -0.6% 0.1% -0.2% 3.1% 11.1% -3.5% -24.6% -23.5% -23.7% -11.1% 25.6% 25.58%
EBITDA 5Y 17.3% 13.4% 20.4% 35.5% 33.2% 32.1% 27.5% 8.2% 9.2% 8.2% 7.2% 5.6% 4.2% 9.0% 5.8% 2.1% 2.2% -0.8% 6.4% 11.5% 11.46%
Gross Profit 3Y 14.5% 16.3% 16.0% 13.9% 11.0% 8.9% 6.7% 5.5% 4.8% 3.7% 3.6% 3.8% 8.0% 10.7% 7.9% 5.2% 5.0% 5.1% 8.4% 11.4% 11.40%
Gross Profit 5Y 14.2% 14.3% 14.4% 14.5% 14.6% 13.9% 13.6% 13.6% 13.7% 12.9% 11.6% 9.3% 8.0% 8.5% 6.2% 4.5% 4.4% 5.3% 7.6% 9.9% 9.93%
Op. Income 3Y 0.3% -2.4% 0.1% 1.9% -5.3% -2.3% -1.4% -3.6% 0.5% -2.5% -2.3% -2.8% 3.7% 11.2% 8.8% 4.9% 8.6% 9.9% 19.0% 30.5% 30.47%
Op. Income 5Y 16.2% 12.8% 12.3% 5.9% 1.8% -0.3% -2.3% -1.8% 0.7% 0.5% 1.8% 1.8% 0.7% 6.2% 4.2% 2.4% 3.0% 1.1% 7.8% 12.7% 12.70%
FCF 3Y 17.0% 12.1% 7.9% 4.2% 4.4% 4.7% 11.3% 17.0% 13.1% 12.3% 6.8% 0.7% 4.5% 8.8% 10.2% 14.0% 14.2% 14.1% 8.9% 3.1% 3.05%
FCF 5Y 19.4% 16.6% 14.2% 12.0% 14.3% 14.5% 18.8% 22.4% 18.0% 14.7% 9.0% 3.2% 5.6% 7.7% 8.0% 9.7% 8.3% 8.8% 10.0% 10.0% 10.04%
OCF 3Y 14.2% 10.8% 7.8% 5.1% 5.0% 5.8% 9.2% 12.3% 7.9% 6.0% 2.2% -1.8% 0.3% 2.6% 3.7% 5.5% 4.5% 3.6% 0.7% -2.5% -2.51%
OCF 5Y 22.7% 19.2% 16.3% 13.7% 14.5% 14.0% 15.2% 16.3% 13.1% 9.9% 5.8% 1.7% 2.5% 3.6% 4.0% 4.9% 3.6% 3.7% 4.2% 4.2% 4.19%
Assets 3Y 47.6% 31.1% 12.5% 17.1% 17.5% 6.7% 8.1% 6.7% 6.0% 3.2% -0.5% -1.3% 0.3% 12.2% 10.0% 5.2% 7.3% 7.3% 8.6% 8.6% 8.62%
Assets 5Y 35.8% 27.9% 26.6% 29.1% 27.9% 26.9% 26.7% 27.1% 25.5% 25.1% 13.7% 13.4% 12.3% 6.0% 4.9% 4.1% 6.9% 5.1% 4.5% 4.0% 4.01%
Equity 3Y 51.3% 22.1% -2.4% 6.6% 13.5% 1.2% 0.6% 0.3% -0.9% -1.5% -1.8% -1.6% 1.2% 25.2% 19.6% 9.2% 3.3% 3.3% 2.5% 2.5% 2.53%
Book Value 3Y 47.0% 12.1% -4.7% 6.0% 12.8% -0.4% 0.2% -0.1% -1.0% -2.0% -1.3% -0.0% 2.2% 25.6% 22.0% 11.3% 5.6% 5.6% 4.5% 4.5% 4.53%
Dividend 3Y -1.7% -3.8% 5.6% 10.8% 17.6% 17.0% 6.7% -5.4% -29.9% -25.9% -19.5% -10.8% 11.6% — -35.8% 1.2% 1.5% — 83.5% 16.4% 16.43%
Growth Quality
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Revenue Stability 0.89 0.90 0.91 0.91 0.90 0.93 0.92 0.89 0.88 0.81 0.81 0.80 0.90 0.89 0.86 0.79 0.86 0.80 0.81 0.68 0.676
Earnings Stability 0.41 0.22 0.29 0.60 0.62 0.47 0.51 0.50 0.27 0.03 0.02 0.00 0.00 0.04 0.07 0.29 0.26 0.01 0.01 0.04 0.039
Margin Stability 0.98 0.99 0.99 0.99 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.99 0.98 0.98 0.98 0.99 0.99 0.98 0.98 0.98 0.979
Rev. Growth Consistency 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.90 0.50 0.50 0.50 0.50 0.50 0.90 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.83 0.96 0.85 0.50 0.500
Earnings Smoothness 0.18 0.77 0.55 0.02 0.00 0.00 0.10 0.71 0.16 0.00 0.00 0.00 0.32 0.30 0.23 0.14 0.65 0.90 0.68 0.36 0.356
ROE Trend -0.09 0.04 0.07 0.23 0.22 0.31 0.26 -0.01 -0.10 -0.30 -0.31 -0.31 -0.22 -0.15 -0.13 -0.05 -0.02 0.02 0.07 0.13 0.131
Gross Margin Trend -0.03 -0.02 -0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.04 0.03 0.02 0.02 -0.01 -0.00 0.01 0.00 0.00 0.01 0.01 0.012
FCF Margin Trend 0.00 0.00 -0.00 -0.00 -0.01 -0.01 0.02 0.05 0.04 0.05 0.01 -0.02 -0.01 -0.02 -0.01 0.02 0.01 0.01 0.01 -0.00 -0.004
Sustainable Growth Rate 9.6% 13.5% 16.7% 34.6% 37.3% 55.6% 50.8% 26.0% 16.1% 4.7% 3.6% 2.5% 6.3% 13.7% 12.0% 9.3% 9.3% 9.8% 13.7% 18.3% 18.29%
Internal Growth Rate 5.3% 6.5% 7.8% 18.5% 22.3% 32.0% 27.8% 13.3% 8.4% 2.3% 1.7% 1.2% 3.1% 7.0% 6.0% 4.6% 4.5% 4.8% 6.3% 8.6% 8.62%
Cash Flow Quality
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
OCF/Net Income 1.40 1.28 1.02 0.49 0.43 0.39 0.46 0.87 1.25 3.04 3.26 3.57 2.07 1.34 1.53 1.79 1.71 1.64 1.21 0.95 0.948
FCF/OCF 0.67 0.67 0.66 0.66 0.64 0.64 0.70 0.75 0.77 0.80 0.77 0.73 0.76 0.80 0.80 0.83 0.84 0.85 0.88 0.88 0.884
FCF/Net Income snapshot only 0.838
OCF/EBITDA snapshot only 0.586
CapEx/Revenue 7.5% 7.5% 7.3% 7.2% 7.5% 7.7% 7.0% 6.3% 5.3% 4.8% 5.0% 5.2% 4.6% 3.7% 4.0% 3.7% 3.4% 3.1% 2.2% 2.0% 2.03%
CapEx/Depreciation snapshot only 0.742
Accruals Ratio -0.03 -0.02 -0.00 0.09 0.12 0.17 0.13 0.02 -0.02 -0.07 -0.06 -0.05 -0.04 -0.02 -0.03 -0.04 -0.04 -0.03 -0.02 0.00 0.005
Sloan Accruals snapshot only 0.146
Cash Flow Adequacy snapshot only 3.864
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 2.15%
Dividend/Share $0.04 $0.05 $0.05 $0.06 $0.07 $0.08 $0.06 $0.05 $0.02 $0.03 $0.03 $0.03 $0.03 $0.00 $0.01 $0.03 $0.03 $0.03 $0.05 $0.05 $0.10
Payout Ratio 21.5% 22.0% 19.3% 10.1% 10.5% 10.5% 9.0% 11.7% 8.9% 30.8% 36.7% 45.4% 24.4% 0.0% 4.1% 17.7% 16.8% 16.0% 17.3% 13.5% 13.53%
FCF Payout Ratio 22.8% 25.6% 28.4% 31.3% 38.3% 42.1% 27.9% 18.0% 9.2% 12.6% 14.7% 17.5% 15.4% 0.0% 3.4% 12.0% 11.7% 11.5% 16.1% 16.1% 16.15%
Total Payout Ratio 22.3% 23.7% 21.5% 11.6% 12.9% 13.4% 14.8% 25.9% 27.8% 72.9% 70.3% 66.4% 41.6% 14.0% 18.9% 39.8% 34.4% 29.5% 31.0% 24.3% 24.32%
Div. Increase Streak 1 1 1 1 1 1 1 0 0 0 0 0 0 — 0 0 0 0 0 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.79 0.83 0.79 0.80 0.81 0.79 0.78 0.71 0.62 0.39 0.35 0.30 0.47 0.63 0.64 0.66 0.57 0.51 0.51 0.51 0.513
Interest Burden (EBT/EBIT) 0.93 0.93 0.96 0.98 1.21 1.46 1.54 2.38 1.61 0.97 0.93 0.89 0.97 1.05 1.04 1.02 1.26 1.49 1.38 1.33 1.328
EBIT Margin 0.23 0.23 0.28 0.54 0.51 0.47 0.42 0.17 0.19 0.21 0.20 0.20 0.21 0.21 0.19 0.18 0.17 0.17 0.22 0.27 0.271
Asset Turnover 0.38 0.45 0.43 0.41 0.41 0.50 0.48 0.46 0.45 0.42 0.40 0.40 0.42 0.48 0.46 0.44 0.42 0.43 0.45 0.50 0.498
Equity Multiplier 1.93 2.20 2.30 2.22 2.05 2.29 2.33 2.21 2.08 2.08 2.17 2.17 2.09 2.09 2.12 2.12 2.14 2.14 2.30 2.30 2.303
Per Share
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.20 $0.22 $0.27 $0.56 $0.67 $0.76 $0.71 $0.42 $0.28 $0.11 $0.09 $0.08 $0.14 $0.23 $0.21 $0.19 $0.20 $0.21 $0.30 $0.38 $0.38
Book Value/Share $1.67 $0.90 $0.97 $1.27 $1.57 $1.57 $1.58 $1.58 $1.57 $1.57 $1.62 $1.62 $1.78 $1.78 $1.76 $1.76 $1.85 $1.85 $1.80 $1.80 $2.56
Tangible Book/Share $0.55 $0.78 $0.88 $1.18 $1.52 $1.48 $1.48 $1.48 $1.52 $1.47 $1.46 $1.46 $1.61 $1.61 $1.59 $1.59 $1.68 $1.68 $1.36 $1.36 $1.36
Revenue/Share $1.21 $1.27 $1.28 $1.31 $1.36 $1.39 $1.42 $1.45 $1.49 $1.38 $1.40 $1.41 $1.48 $1.69 $1.65 $1.59 $1.65 $1.70 $1.87 $2.05 $1.87
FCF/Share $0.19 $0.19 $0.18 $0.18 $0.18 $0.19 $0.23 $0.27 $0.27 $0.27 $0.23 $0.19 $0.22 $0.25 $0.26 $0.28 $0.29 $0.30 $0.32 $0.32 $0.29
OCF/Share $0.28 $0.29 $0.28 $0.28 $0.29 $0.30 $0.33 $0.36 $0.35 $0.33 $0.30 $0.27 $0.29 $0.31 $0.33 $0.34 $0.35 $0.35 $0.36 $0.36 $0.34
Cash/Share $0.98 $0.88 $0.54 $0.54 $0.82 $0.82 $0.82 $0.82 $0.89 $0.89 $0.84 $0.84 $0.71 $0.72 $0.80 $0.80 $1.10 $1.10 $1.53 $1.53 $0.82
EBITDA/Share $0.32 $0.30 $0.40 $0.74 $0.71 $0.71 $0.64 $0.29 $0.33 $0.33 $0.34 $0.34 $0.36 $0.41 $0.38 $0.34 $0.34 $0.34 $0.47 $0.61 $0.61
Debt/Share $0.75 $0.76 $0.71 $0.71 $0.63 $0.63 $0.63 $0.63 $0.74 $0.74 $0.62 $0.62 $0.52 $0.53 $0.54 $0.54 $0.66 $0.66 $0.95 $0.95 $0.95
Net Debt/Share $-0.22 $-0.12 $0.18 $0.17 $-0.19 $-0.19 $-0.19 $-0.19 $-0.15 $-0.16 $-0.22 $-0.22 $-0.19 $-0.19 $-0.26 $-0.26 $-0.44 $-0.44 $-0.58 $-0.58 $-0.58
Academic Models
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 4 7 6 6 6 4 6 5 5 5 5 5 6 7 9 9 8 6 7 7 7
Beneish M-Score -2.52 -2.71 -2.41 -1.94 -1.74 -1.18 -1.30 -2.32 -2.48 -2.58 -2.36 -2.34 -2.20 -1.75 -2.91 -2.96 -2.54 -2.53 -1.71 -1.64 -1.635
Ohlson O-Score snapshot only -9.803
ROIC (Greenblatt) snapshot only 36.99%
Net-Net WC snapshot only $0.39
EVA snapshot only $6650063051.78
Credit
Metric Trend Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 75.50 74.55 76.05 77.55 77.40 78.30 78.30 72.80 72.50 72.50 74.00 74.00 74.00 74.00 74.60 77.75 74.00 74.00 73.10 74.60 74.600
Credit Grade snapshot only 6
Credit Trend snapshot only -3.150
Implied Spread (bps) snapshot only 150.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms